An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
نویسندگان
چکیده
منابع مشابه
Etiopathogenesis of Alopecia Areata
Alopecia areata (AA) is a recurrent, non-scarring type of hair loss affecting the hair follicles and sometimes the nails. Current evidence indicates that hair follicle inflammation in alopecia areata is caused by a T-cell mediated autoimmune mechanism occurring in genetically predisposed individuals. Environmental factors like infections, diet, vaccination and stress may be responsible for trig...
متن کاملManagement of alopecia areata
Epithelial Sciences, School of Translational Medicine, University of Manchester, Manchester Jackson Laboratory, Bar Harbor, ME, USA Department of Dermatology, China-Japan Union Hospital of JiLin University, Chang Chun, People’s Republic of China Department of Dermatology, University of Lübeck, D-23538 Lübeck, Germany Skin Disease Research Centre, Division of Dermatology, Vanderbilt Medical Cent...
متن کاملAlopecia areata in patients with inflammatory bowel disease: an overview.
Alopecia areata (AA) is one of the most common causes of non-scarring hair loss, which is associated with the premature induction of hair follicle regression. The pathogenesis of AA is unknown, although it is believed that a complicated autoimmune mechanism with Th1 lymphocytes and proinfammatory cytokines, such as IFN-γ, TNF-α, IL-1 and IL-2, may be involved. AA may occur as a single disease e...
متن کاملAlopecia areata: an update.
Alopecia areata (AA) is a common form of non-scarring hair loss of scalp and/or body. Genetic predisposition, autoimmunity, and environmental factors play a major role in the etiopathogenesis of AA. Patchy AA is the most common form. Atopy and autoimmune thyroiditis are most common associated conditions. Peribulbar and intrabulbar lymphocytic inflammatory infiltrate resembling "swarm of bees" i...
متن کاملAlopecia areata.
n engl j med 367;3 nejm.org july 19, 2012 279 methacin should be used in addition to pancre atic stents in highrisk patients. However, post hoc analysis of our trial suggests that indometha cin may obviate the need for prophylactic pan creatic stent placement (unpublished data), and we therefore agree with Baron et al. that com parative effectiveness studies of indomethacin and pancreatic ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Egyptian Journal of Hospital Medicine
سال: 2023
ISSN: ['1687-2002', '2090-7125']
DOI: https://doi.org/10.21608/ejhm.2023.309940